Designing HIV Vaccination Policies: Subtypes and Cross-Immunity

Published Online:https://doi.org/10.1287/inte.28.3.167

References

  • Anderson R. M. , May R. M. Infectious Diseases of Humans: Dynamics and Control (1991) (Oxford University Press, Oxford, England) CrossrefGoogle Scholar
  • Artenstein A. W. , VanCott T. C. , Mascola J. R. , Carr J. K. , Hegerich P. A. , Gaywee J. , Sanders-Buell E. , Robb M. L. , Dayhoff D. E. , Thitivichianlert S. , Nitayaphan S. , McNeil J. G. , Birx D. L. , Michael R. A. , Burke D. S. , McCutchan F. E. Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. J. Infectious Diseases (1995) 171 4 805 810 CrossrefGoogle Scholar
  • Bloom B. R. A perspective on AIDS vaccines. Science (1996) 272 5270 1888 1890 CrossrefGoogle Scholar
  • Blower S. M. , McLean A. R. Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. Science (1994) 265 5177 1451 1454 CrossrefGoogle Scholar
  • Blower S. M. , McLean A. R. AIDS: Modeling epidemic control. Science (1995) 267 5202 1250 1253 CrossrefGoogle Scholar
  • Burke D. S. , McCutchan F. E. , DeVita V. T. , Hellman S. , Rosenberg S. A. Global distribution of human immunodeficiency virus-1 clades. AIDS: Biology, Diagnosis, Treatment and Prevention (1997) (Lippincott-Raven, Philadelphia, Pennsylvania) 119 126 Google Scholar
  • Cohen J. Are researchers racing toward success, or crawling? Science (1994) 265 5177 1373 1375 CrossrefGoogle Scholar
  • Ferrari G. , Humphrey W. , McElrath M. J. , Excler J.-L. , Duliege A.-M. , Clements M. L. , Corey L. C. , Bolognesi D. P. , Weinhold K. J. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc. National Academy of Science of the United States of America (1997) 94 4 1396 1401 CrossrefGoogle Scholar
  • Fisher A. G. , Ensoli B. , Looney D. , Rose A. , Gallo R. C. , Saag M. S. , Shaw G. M. , Hahn B. H. , Wong-Staal F. Biologically diverse molecular variants within a single HIV-1 isolate. Nature (1988) 334 6181 444 447 CrossrefGoogle Scholar
  • Grady C. , Kelly G. State of the science: HIV vaccine development. Nursing Clinics of North America (1996) 31 1 25 39 Google Scholar
  • Grant R. M. , Wiley J. A. , Winkelstein W. Infectivity of the human immunodeficiency virus: Estimates from a prospective study of homosexual men. J. Infectious Diseases (1987) 156 1 189 193 CrossrefGoogle Scholar
  • Horn R. A. , Johnson C. R. Matrix Analysis (1985) (Cambridge University Press, Cambridge, England) CrossrefGoogle Scholar
  • Hu D. J. , Dondero T. J. , Rayfield M. A. , George J. R. , Schochetman G. , Jaffe H. W. , Luo C. C. , Kalish M. L. , Weniger B. G. , Pau C. P. The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. J. Amer. Medical Assoc. (1996) 275 3 210 216 CrossrefGoogle Scholar
  • Kalish M. L. , Baldwin A. , Raktham S. , Wasi C. , Luo C.-C. , Schochetman G. , Mastro T. D. , Young N. , Vanichseni S. , Rübsamen-Waigmann H. , von Breisen H. , Mullins J. I. , Delwart E. , Herring B. , Esparza J. , Heyward W. L. , Osmanov S. The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: Implications for HIV vaccine trials. AIDS (1995) 9 8 851 857 CrossrefGoogle Scholar
  • Kanki P. , Travers K. U. , Mboup S. , Hsieh C.-C. , Marlink R. G. , Guèye-Ndiaye A. , Siby T. , Thior I. , Hernandez-Avila M. , Sankalé J.-L. , Ndoye I. , Essex M. E. Slower heterosexual spread of HIV-2 than HIV-1. Lancet (1994) 343 8903 943 946 CrossrefGoogle Scholar
  • Kermack W. O. , McKendrick A. G. A contribution to the mathematical theory of epidemics. Proc. Royal Society of London, A (1927) 115 772 700 721 CrossrefGoogle Scholar
  • Kuiken C. L. , Zwart G. , Baan E. , Coutinho R. A. , van den Hoek J. A. , Goudsmit J. Increasing antigenic and genetic diversity of the V3 variable domain of the human immunodeficiency virus envelope protein in the course of the AIDS epidemic. Proc. National Academy of Sciences of the United States of America (1993) 90 19 9061 9065 CrossrefGoogle Scholar
  • Kunanusont C. , Foy H. M. , Kreiss J. K. , Rerks-Ngarm S. , Phanuphak P. , Raktham S. , Pau C.-P. , Young N. L. HIV-1 subtypes and male-to-female transmission in Thailand. Lancet (1995) 345 8957 1078 83 CrossrefGoogle Scholar
  • Levy J. A. , Mann J. M. , Tarantola D. J. M. HIV heterogeneity in transmission and pathogenesis. AIDS in the World II, Global Dimensions, Social Roots, and Responses (1996) (Oxford University Press, New York) 177 185 Google Scholar
  • MacDonald G. The Epidemiology and Control of Malaria (1957) (Oxford University Press, London, England) Google Scholar
  • Marlink R. , Kanki P. , Thior I. , Travers K. , Eisen G. , Siby T. , Traore I. , Hsieh C.-C. , Dia M. , Gueye E.-H. , Hellinger J. , Guèye-Ndiaye A. , Sankalé J.-L. , Ndoye I. , Mboup S. , Essex M. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science (1994) 265 8903 1587 1590 CrossrefGoogle Scholar
  • Mascola J. R. , Louwagie J. , McCutchan F. E. , Fischer C. L. , Hegerich P. A. , Wagner K. F. , Fowler A. K. , McNeil J. G. , Burke D. S. Two antigenically distinct subtypes of human immunodeficiency virus type 1: Viral genotype predicts neutralization serotype. J. Infectious Diseases (1994) 169 1 48 54 CrossrefGoogle Scholar
  • Mascola J. R. , Snyder S. W. , Weislow O. S. , Belay S. M. , Belshe R. B. , Schwartz D. H. , Clements M. L. , Dolin R. , Graham B. S. , Gorse G. J. , Keefer M. C. , McElrath M. J. , Walker M. C. , Wagner K. F. , McNeil J. G. , McCutchan F. E. , Burke D. S. Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. J. Infectious Diseases (1996) 173 2 340 348 CrossrefGoogle Scholar
  • Mastro T. D. , Satten G. A. , Nopkesorn T. , Sangkharomya S. , Longini I. M. Probability of female-to-male transmission of HIV-1 in Thailand. Lancet (1994) 343 8891 204 207 CrossrefGoogle Scholar
  • McCutchan F. , Hegerich P. , Brennan T. , Phanuphak P. , Singharaj P. , Jugsudee A. , Berman P. , Gray A. , Fowler A. , Burke D. Genetic variants of HIV in Thailand. AIDS Res. Human Retroviruses (1992) 8 11 1887 1895 CrossrefGoogle Scholar
  • McCutchan F. E. , Salminen M. O. , Carr J. K. , Burke D. S. HIV-1 genetic diversity. AIDS (1996) 10 Suppl. 3 S13 S20 CrossrefGoogle Scholar
  • McLean A. R. Vaccination, evolution and changes in the efficacy of vaccines: A theoretical framework. Proc. Royal Society of London, Series B (1995) 261 1362 389 393 CrossrefGoogle Scholar
  • McLean A. R. , Blower S. M. Imperfect vaccines and herd immunity to HIV. Proc. Royal Society of London, Series B (1993) 253 1336 9 13 CrossrefGoogle Scholar
  • McLean A. R. , Blower S. M. Modelling HIV vaccination. Trends in Microbiology (1995) 3 12 458 463 CrossrefGoogle Scholar
  • Mertens T. , Piot P. , DeVita V. T. , Hellman S. , Rosenberg S. A. Global aspects of human immunodeficiency virus epidemiology: General considerations. AIDS: Biology, Diagnosis, Treatment and Prevention (1997) (Lippincott-Raven, Philadelphia, Pennsylvania) 103 118 Google Scholar
  • Osmond D. H. , Page K. , Wiley J. , Garrett K. , Sheppard H. W. , Moss A. R. , Schrager L. , Winkelstein W. HIV infection in homosexual and bisexual men 18 to 29 years of age: The San Francisco young men's health study. Amer. J. Public Health (1994) 84 12 1933 1937 CrossrefGoogle Scholar
  • Ou C. Y. , Takebe Y. , Weniger B. , Luo C. Y. , Kalish M. , Auwant W. , Yamazaki S. , Gayle H. , Young N. , Schochetman G. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet (1993) 341 8854 1171 1174 CrossrefGoogle Scholar
  • Porco T. C. , Blower S. M. HIV vaccines: Subtypes, cross-immunity, and risk behavior change. (1997) . Working paper Google Scholar
  • Rojas J. M. , Dopazo J. , Najera I. , Sánchez-Palomino S. , Olivares I. , Martin M. J. , Bernal A. , Garcia-Saiz A. , Najera R. , Lopez-Galindez C. Molecular epidemiology of HIV-1 in Madrid. Virus Res. (1994) 31 3 331 342 CrossrefGoogle Scholar
  • Rowe P. M. HIV subtypes raise vaccine anxieties. Lancet (1996) 347 9001 603 CrossrefGoogle Scholar
  • Saag M. S. , Hahn B. H. , Gibbons J. , Li Y. , Parks E. S. , Parks W. P. , Shaw G. M. Extensive variation of human immunodeficiency virus type-1 in vivo. Nature (1988) 334 6181 440 443 CrossrefGoogle Scholar
  • Sánchez-Palomino S. , Dopazo J. , Olivares I. , Martin M. J. , López-Galíndez C. Primary genetic characterization of HIV-1 isolates from WHO-sponsored vaccine evaluation sites by the RNase-A mismatch method. Virus Res. (1995) 39 2–3 251 259 CrossrefGoogle Scholar
  • Soto-Ramirez L. E. , Renjifo B. , McLane M. F. , Marlink R. , O'Hara C. , Sutthent R. , Wasi C. , Vithayasai P. , Vithayasai V. , Apichartpiyakul C. , Auewarakul P. , Cruz V. P. , Chui D.-S. , Osathanondh R. , Mayer K. , Lee T.-H. , Essex M. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science (1996) 271 5253 1291 1293 CrossrefGoogle Scholar
  • Travers K. , Mboup S. , Marlink R. , Guèye-Ndiaye A. , Siby T. , Thior I. , Traore I. , Dieng-Sarr A. , Sankalé J.-L. , Mullins C. , Ndoye I. , Hsieh C.-C. , Essex M. , Kanki P. Natural protection against HIV-1 infection provided by HIV-2. Science (1995) 268 5217 1612 1615 CrossrefGoogle Scholar
  • Verani P. , Butto S. , Taddeo B. , Federico M. , Rossi G. B. HIV variability and perspectives for a vaccine. Vaccine (1993) 11 5 542 544 CrossrefGoogle Scholar
  • WHO network for HIV isolation and characterization HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: Genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res. Human Retroviruses (1994) 10 11 1327 1343 CrossrefGoogle Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.